Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended March 31, 2018
Compliance certificate under Regulation 7(3) of SEBI LODR07-04-2018
07-04-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Intimation under regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 201527-03-2018
Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation for quarter and nine months ended December17-03-2018
Announcement under Regulation 30 (LODR)-Updates
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 ('the SEBI LODR')15-02-2018
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Shalby Jaipur with 237 bed capacity launches its state of- the art Radiation Therapy Centre12-02-2018
Company news: Shalby Hospitals
Shalby Hospitals (Shalby Ltd) has launched a radiotherapy centre at its recently-commissioned Naroda Shalby Hospital for treatment of cancer patients. Naroda Shalby, 267-bed capaci06-02-2018
Press Release / Media Release
Shalby Naroda with 267 bed capacity Launches its state-of-the art Radiation Therapy Centre06-02-2018
Disclosure Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015 ('The SEBI LODR')
In terms of Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we are enclosing herewith statement of Utilization of issue proceeds as reviewed by Audit Committee at its meeting held on 9th January 2018. We also enclose herewith report of the monitoring agency for utilization of issue proceeds for our Company's Initial Public Offer for the quarter ended December 31, 2017.25-01-2018
Shareholding for the Period Ended December 31, 2017
Shalby Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click here12-01-2018
Statement Of Investor Complaint For Quarter Ended December 31, 2017 Under Regulation 13(3) Of SEBI LODR
Statement of Investor Complaint for quarter ended December 31, 2017 under Regulation 13(3) of SEBI LODR10-01-2018